Cargando…

Transcriptomic signature defines two subtypes of locally advanced PCa with distinct neoadjuvant therapy benefits

BACKGROUND: Patients with locally advanced prostate cancer (LAPCa) received docetaxel-based neoadjuvant chemo-hormonal therapy (NCHT) had better clinical outcomes after surgery compared to neoadjuvant hormonal therapy (NHT) groups, but not all patients experienced favorable clinical outcomes with NC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yinjie, Fan, Liancheng, Zhu, Hanjing, Gong, Yiming, Chi, Chenfei, Wang, Yanqing, Pan, Jiahua, Dong, Baijun, Xue, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229793/ https://www.ncbi.nlm.nih.gov/pubmed/37265786 http://dx.doi.org/10.3389/fonc.2023.963411

Ejemplares similares

Efficacy of neoadjuvant docetaxel + cisplatin chemo-hormonal therapy versus docetaxel chemo-hormonal therapy in patients with locally advanced prostate cancer with germline DNA damage repair gene alterations
por: Chi, Chenfei, et al.
Publicado: (2022)

Early Plasma Circulating Tumor DNA as a Potential Biomarker of Disease Recurrence in Non-metastatic Prostate Cancer
por: Fei, Xiaochen, et al.
Publicado: (2023)

Early serial circulating tumor DNA sequencing predicts the efficacy of chemohormonal therapy in patients with metastatic hormone-sensitive prostate cancer
por: Du, Xinxing, et al.
Publicado: (2023)

Abiraterone acetate for chemotherapy-naive metastatic castration-resistant prostate cancer: a single-centre prospective study of efficacy, safety, and prognostic factors
por: Fan, Liancheng, et al.
Publicado: (2018)

The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study
por: Fei, Xiaochen, et al.
Publicado: (2021)

Extended lymphadenectomy for high-risk prostate cancer in patients with chronic lymphocytic leukemia may not be necessary: a report of two cases
por: Zhu, Yinjie, et al.
Publicado: (2019)

Serum Pre-Albumin Predicts the Clinical Outcome in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone
por: Fan, Liancheng, et al.
Publicado: (2017)

PRKAR2B‐HIF‐1α loop promotes aerobic glycolysis and tumour growth in prostate cancer
por: Xia, Lei, et al.
Publicado: (2020)

Surface-enhanced Raman spectroscopy before radical prostatectomy predicts biochemical recurrence better than CAPRA-S
por: Pan, Jiahua, et al.
Publicado: (2019)

Albumin and Fibrinogen Combined Prognostic Grade Predicts Prognosis of Patients with Prostate Cancer
por: Wang, Yanqing, et al.
Publicado: (2017)

Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma
por: Lu, Huan, et al.
Publicado: (2020)

High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma
por: Raffeld, Mark, et al.
Publicado: (2020)

AB140. Efficacy of radical prostatectomy combined with neoadjuvant chemotherapy in the treatment of locally advanced prostate cancer: preliminary experiences from a single center
por: Xue, Wei, et al.
Publicado: (2016)

Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer
por: Dong, Baijun, et al.
Publicado: (2020)

Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy
por: Wang, Yanqing, et al.
Publicado: (2016)

Characteristics and Validation Techniques for PCA-Based Gene-Expression Signatures
por: Berglund, Anders E., et al.
Publicado: (2017)

Replication Stress Defines Distinct Molecular Subtypes Across Cancers
por: Takahashi, Nobuyuki, et al.
Publicado: (2022)

Molecular signatures define alopecia areata subtypes and transcriptional biomarkers
por: Jabbari, Ali, et al.
Publicado: (2016)

Dynamic Meta-data Network Sparse PCA for Cancer Subtype Biomarker Screening
por: Miao, Rui, et al.
Publicado: (2022)

Distinct Murine Pancreatic Transcriptomic Signatures during Chronic Pancreatitis Recovery
por: Zhang, Yinjie, et al.
Publicado: (2021)

m(6)A-induced repression of SIAH1 facilitates alternative splicing of androgen receptor variant 7 by regulating CPSF1
por: Xia, Lei, et al.
Publicado: (2022)

The Microbiome of Prostate Fluid Is Associated With Prostate Cancer
por: Ma, Xiaowei, et al.
Publicado: (2019)

Transcriptome and Metabolome Reveal Distinct Sugar Accumulation Pattern between PCNA and PCA Mature Persimmon Fruit
por: Han, Weijuan, et al.
Publicado: (2023)

FGFR1 expression defines clinically distinct subtypes in pancreatic cancer
por: Haq, Farhan, et al.
Publicado: (2018)

Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer’s disease
por: Ossenkoppele, Rik, et al.
Publicado: (2020)

Immunological profiles of human oligodendrogliomas define two distinct molecular subtypes
por: Wu, Fan, et al.
Publicado: (2022)

Potential Benefits of Neoadjuvant Chemotherapy in Clinically Node-Positive Luminal Subtype(−) Breast Cancer
por: Kim, Hyung Suk, et al.
Publicado: (2019)

Distinct T cell signatures define subsets of patients with multiple sclerosis
por: Johnson, Mark C., et al.
Publicado: (2016)

EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastoma
por: Lucas, Calixto-Hope G., et al.
Publicado: (2021)

Improving RLRN Image Splicing Detection with the Use of PCA and Kernel PCA
por: Moghaddasi, Zahra, et al.
Publicado: (2014)

Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome
por: Marziali, G., et al.
Publicado: (2016)

Distinct neural signatures of cognitive subtypes of dyslexia with and without phonological deficits()
por: van Ermingen-Marbach, Muna, et al.
Publicado: (2013)

Distinct molecular subtypes of systemic sclerosis and gene signature with diagnostic capability
por: Wang, Qi, et al.
Publicado: (2023)

The Diagnostic Value of PI-RADS v2.1 in Patients with a History of Transurethral Resection of the Prostate (TURP)
por: Liu, Jiazhou, et al.
Publicado: (2022)

PEM-PCA: A Parallel Expectation-Maximization PCA Face Recognition Architecture
por: Rujirakul, Kanokmon, et al.
Publicado: (2014)

Consequences of PCA graphs, SNP codings, and PCA variants for elucidating population structure
por: Gauch, Hugh G., et al.
Publicado: (2019)

MMR Deficiency Defines Distinct Molecular Subtype of Breast Cancer with Histone Proteomic Networks
por: Hacking, Sean, et al.
Publicado: (2023)

Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes
por: Liu, Si-Yang, et al.
Publicado: (2021)

Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer
por: Robertson, A. Gordon, et al.
Publicado: (2023)

DLPFC transcriptome defines two molecular subtypes of schizophrenia
por: Bowen, Elijah F. W., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ga4g961rt6t8ofe61kaab8rmas